123 related articles for article (PubMed ID: 8221685)
1. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.
Kostenuik PJ; Orr FW; Suyama K; Singh G
Cancer Res; 1993 Nov; 53(22):5452-7. PubMed ID: 8221685
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone.
Kostenuik PJ; Singh G; Suyama KL; Orr FW
Clin Exp Metastasis; 1992 Nov; 10(6):411-8. PubMed ID: 1451351
[TBL] [Abstract][Full Text] [Related]
3. A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells.
Kostenuik PJ; Singh G; Suyama KL; Orr FW
Clin Exp Metastasis; 1992 Nov; 10(6):403-10. PubMed ID: 1451350
[TBL] [Abstract][Full Text] [Related]
4. Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis.
Manishen WJ; Sivananthan K; Orr FW
Am J Pathol; 1986 Apr; 123(1):39-45. PubMed ID: 3457536
[TBL] [Abstract][Full Text] [Related]
5. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo.
Soares FA; Shaughnessy SG; MacLarkey WR; Orr FW
Lab Invest; 1994 Oct; 71(4):480-9. PubMed ID: 7967504
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases.
Badraoui R; Blouin S; Moreau MF; Gallois Y; Rebai T; Sahnoun Z; Baslé M; Chappard D
Chem Biol Interact; 2009 Dec; 182(2-3):98-105. PubMed ID: 19781538
[TBL] [Abstract][Full Text] [Related]
7. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
Henriksen G; Breistøl K; Bruland ØS; Fodstad Ø; Larsen RH
Cancer Res; 2002 Jun; 62(11):3120-5. PubMed ID: 12036923
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat Walker 256 carcinosarcoma cells.
Orr FW; Millar-Book W; Singh G
Invasion Metastasis; 1990; 10(4):241-52. PubMed ID: 2358328
[TBL] [Abstract][Full Text] [Related]
9. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].
Yao M; Yang JP; Wang LN; Cheng H; Zhang YB; Xu QN; Wu YW
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):880-4. PubMed ID: 18756951
[TBL] [Abstract][Full Text] [Related]
12. Distribution of 3-amino-1-hydroxypropane-1,1-diphosphonic acid in rats and effects on rat osteosarcoma.
Wingen F; Schmähl D
Arzneimittelforschung; 1985; 35(10):1565-71. PubMed ID: 3865653
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
15. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
[TBL] [Abstract][Full Text] [Related]
19. Pamidronate prevents the development of skeletal metastasis in nude mice transplanted with human breast cancer cells by reducing tumor burden within bone.
El-Abdaimi K; Ste-Marie LG; Papavasiliou V; Dion N; Cardinal PE; Huang D; Kremer R
Int J Oncol; 2003 Apr; 22(4):883-90. PubMed ID: 12632083
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of bisphosphonates.
Green JR
Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
